Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Cancer Discovery, ISSN: 2159-8290, Vol: 12, Issue: 10, Page: 2330-2349
2022
- 41Citations
- 10Usage
- 70Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations41
- Citation Indexes41
- 41
- Usage10
- Downloads10
- Captures70
- Readers70
- 70
Article Description
Pancreatic ductal adenocarcinoma (PDAC) has few effective treatments. Immu-notherapy, an attractive alternative strategy, remains challenging with the lack of knowledge on the tumor-infiltrating lymphocyte (TIL) landscape in PDAC. To generate a reference of T-cell subpopulations, we profiled 80,000 T cells from 57 PDAC samples, 22 uninvolved/normal sam-ples, and cultured TIL using single-cell transcriptomic and T-cell receptor analysis. These data revealed 20 cell states and heterogeneous distributions of TIL populations. The CD8 TIL contained a putative transitional GZMK population based on T-cell receptor clonotype sharing, and cell-state trajectory analysis showed similarity to a GZMBPRF1 cytotoxic and a CXCL13 dysfunctional population. Statistical analysis suggested that certain TIL states, such as dysfunctional and inhibitory populations, often occurred together. Finally, analysis of cultured TIL revealed that high-frequency clones from effector populations were preferentially expanded. These data provide a framework for understanding the PDAC TIL landscape for future TIL use in immunotherapy for PDAC.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85139525204&origin=inward; http://dx.doi.org/10.1158/2159-8290.cd-21-1248; http://www.ncbi.nlm.nih.gov/pubmed/35849783; https://aacrjournals.org/cancerdiscovery/article/12/10/2330/709454/Single-Cell-Sequencing-Reveals-Trajectory-of-Tumor; https://digitalcommons.library.tmc.edu/uthgsbs_docs/1015; https://digitalcommons.library.tmc.edu/cgi/viewcontent.cgi?article=1992&context=uthgsbs_docs; https://dx.doi.org/10.1158/2159-8290.cd-21-1248
American Association for Cancer Research (AACR)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know